Opportunity

Simpler Grants.gov #RFA-DK-27-136

NIH Solicits Research Coordinating Center for Youth Anti-Obesity Medication Consortium

Buyer

National Institutes of Health

Posted

October 04, 2023

Respond By

December 01, 2026

Identifier

RFA-DK-27-136

NAICS

541715

The National Institutes of Health (NIH) is seeking a Research Coordinating Center (RCC) to support a consortium focused on anti-obesity medication (AOM) strategies for youth. - Government Buyer: - National Institutes of Health (NIH) - OEMs and Vendors: - No specific OEMs or vendors are named, as this is a research coordination grant opportunity - Products/Services Requested: - Research Coordinating Center services to: - Provide management and administrative support for a multi-center research consortium - Lead statistical design and analysis for clinical trials - Coordinate with a central laboratory and harmonize data collection methods - Manage data and analyses across participating sites - Foster research collaborations and protocol development - Support use of common measures and data elements in multicenter trials - Unique or Notable Requirements: - Eligible applicants include educational, governmental, nonprofit, and business entities, including foreign institutions - Emphasis on harmonization of data and collaboration across multiple clinical centers - No specific products, part numbers, or OEMs are required, as the focus is on research coordination and management services

Description

This Notice of Funding Opportunity invites applications for a Research Coordinating Center (RCC) to support a consortium of clinical centers testing anti-obesity medication treatment strategies for youth with obesity. The RCC will provide management, leadership in statistical design and analysis, research coordination, and foster collaborations. The consortium aims to determine optimal treatment parameters such as developmental stage for initiation, dosage, and adjunct lifestyle therapies. The RCC will harmonize data collection, manage data and analyses, and support multicenter trials.

View original listing